Inverse interference: How viruses fight the interferon system

Viral Immunology

Volumn 17, Issue 4, 2004, Pages 498-515

  Weber, Friedemann ^a   Kochs, Georg ^a   Haller, Otto ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; ANTIVIRUS PROTEIN; BETA INTERFERON; BINDING PROTEIN; DOUBLE STRANDED RNA; GENE PRODUCT; GUANOSINE TRIPHOSPHATASE; INTERFERON REGULATORY FACTOR 1; JANUS KINASE; MYXOVIRUS RESISTANCE PROTEIN; MYXOVIRUS RESISTANCE PROTEIN A; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN GBP1; PROTEIN MX1; PROTEIN ND10; PROTEIN PKR; PROTEIN SERINE THREONINE KINASE; STAT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL METABOLISM; CELL SURVIVAL; CONTROLLED STUDY; DRUG DESIGN; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENE TARGETING; HOST CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; INVERSE INTERFERENCE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALIA; JANUS; MYXOVIRUS; RNA VIRUSES;

EID: 11144240264     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2004.17.498     Document Type: Review

References (246)

1. Ahmed, M., M.O. McKenzie, S. Puckett, et al. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress Beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 77:4646-4657.
2. Alcami, A., and G.L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:4633-4639.
3. Alcami, A., J.A. Symons, and G.L. Smith. 2000. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 74:11230-11239.
4. Anderson, S.L., J.M. Carton, J. Lou, et al. 1999. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256:8-14.
5. Andrejeva, J., D.F. Young, S. Goodbourn, et al. 2002. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76:2159-2167.
6. Antonelli, G., E. Simeoni, O. Turriziani, et al. 1999. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy. J. Interferon Cytokine Res. 19:243-251.
7. Arnheiter, H., M. Frese, R. Kambadur, et al. 1996. Mx transgenic mice-animal models of health. Curr. Top. Microbiol. Immunol. 206:119-147.
8. Atreya, P.L., and S. Kulkarni. 1999. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology 261: 227-241.
9. Au, W.C., P.A. Moore, D.W. LaFleur, et al. 1998. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem. 273:29210-29217.
10. Baigent, S.J., G. Zhang, M.D. Fray, et al. 2002. Inhibition of beta interferon transcription by noncytopathogenic bovine viral diarrhea virus is through an interferon regulatory factor 3-dependent mechanism. J. Virol. 76: 8979-8988.
11. Balachandran, S., and G.N. Barber. 2004. Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5:51-65.
12. Balachandran, S., P.C. Roberts, L.E. Brown, et al. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141.
13. Basler, C.F., and A. Garcia-Sastre. 2002. Viruses and the type I interferon antiviral system: induction and evasion. Int. Rev. Immunol. 21:305-337.
14. Basler, C.F., A. Mikulasova, L. Martinez-Sobrido, et al. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77:7945-7956.
15. Bazzigher, L., J. Pavlovic, O. Haller, et al. 1992. Mx genes show weaker primary response to virus than other interferon-regulated genes. Virology 186:154-160.
16. Benedict, C.A., T.A. Banks, L. Senderowicz, et al. 2001. Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 15:617-626.
17. Bergmann, M., A. Garcia-Sastre, E. Carnero, et al. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74:6203-6206.
18. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-263.
19. Billecocq, A., M. Spiegel, P. Vialat, et al. 2004. NSs protein of Rift Valley Fever Virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78:9798-9806.
20. Black, T.L., G.N. Barber, and M.G. Katze. 1993. Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA. J. Virol. 67:791-800.
21. Bode, J.G., S. Ludwig, C. Ehrhardt, et al. 2003. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 17:488-490.
22. Boehme, K.W., and T. Compton. 2004. Innate sensing of viruses by toll-like receptors. J. Virol. 78:7867-7873.
23. Bossert, B., S. Marozin, and K.K. Conzelmann. 2003. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77:8661-8668.
24. Bouloy, M., C. Janzen, P. Vialat, et al. 2001. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J. Virol. 75:1371-1377.
25. Boutell, C., S. Sadis, and R.D. Everett. 2002. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76:841-850.
26. Bray, M. 2001. The role of the Type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 82:1365-1373.
27. Burysek, L., and P.M. Pitha. 2001. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J. Virol. 75:2345-2352.
28. Burysek, L., W.S. Yeow, B. Lubyova, et al. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 73:7334-7342.
29. Burysek, L., W.S. Yeow, and P.M. Pitha. 1999. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 2:19-32.
30. Cayley, P.J., J.A. Davies, K.G. McCullagh, et al. 1984. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur. J. Biochem. 143:165-174.
31. Chatziandreou, N., D. Young, J. Andrejeva, et al. 2002. Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293:234-242.
32. Chee, A.V., P. Lopez, P.P. Pandolfi, et al. 2003. Promyelocytic leukemia protein mediates interferon-based antiherpes simplex virus 1 effects. J. Virol. 77:7101-7105.
33. Chee, A.V., and B. Roizman. 2004. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J. Virol. 78:4185-4196.
34. Chelbi-Alix, M.K., F. Quignon, L. Pelicano, et al. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72:1043-1051.
35. Chen, Z., Y. Li, and R.M. Krug. 1999. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J. 18:2273-2283.
36. Chinsangaram, J., M.E. Piccone, and M.J. Grubman. 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
37. Chu, W.M., D. Ostertag, Z.W. Li, et al. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11:721-731.
38. Clark, M.E., P.M. Lieberman, A.J. Berk, et al. 1993. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol. Cell. Biol. 13:1232-1237.
39. Coffey, M.C., J.E. Strong, P.A. Forsyth, et al. 1998. Reovirus therapy of tumors with activated Ras pathway. Science 282:1332-1334.
40. Colonna, M., A. Krug, and M. Cella. 2002. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14:373-379.
41. Connor, J.H., and D.S. Lyles. 2002. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J. Virol. 76:10177-10187.
42. Dauber, B., G. Heins, and T. Wolff. 2004. The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J. Virol. 78:1865-1872.
43. Davies, M.V., O. Elroy-Stein, R. Jagus, et al. 1992. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA- activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66:1943-1950.
44. de Veer, M.J., M. Holko, M. Frevel, et al. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
45. Deisenhammer, F., H. Schellekens, and A. Bertolotto. 2004. Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis. J. Neurol. 251(Suppl 2):II31-II39.
46. Delhaye, S., V. van Pesch, and T. Michiels. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:4357-4362.
47. Der, S.D., A. Zhou, B.R. Williams, et al. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
48. Didcock, L., D.F. Young, S. Goodbourn, et al. 1999. Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J. Virol. 73:3125-3133.
49. Didcock, L., D.F. Young, S. Goodbourn, et al. 1999. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:9928-9933.
50. Diebold, S.S., T. Kaisho, H. Hemmi, et al. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531.
51. Diebold, S.S., M. Montoya, H. Unger, et al. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324-328.
52. Djavani, M., J. Rodas, I.S. Lukashevich, et al. 2001. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J. Virol. 75:6204-6208.
53. Duerst, R.J., and L.A. Morrison. 2004. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 322:158-167.
54. Dupuis, S., E. Jouanguy, S. Al-Hajar, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388-391.
55. Elia, A., K.G. Laing, A. Schofield, et al. 1996. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res. 24:4471-4478.
56. Engelhardt, O.G., H. Sirma, P.P. Pandolfi, et al. 2004. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J. Gen. Virol. 85:2315-2326.
57. Espert, L., G. Degols, C. Gongora, et al. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278: 16151-16158.
58. Ferran, M.C., and J.M. Lucas-Lenard. 1997. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J. Virol. 71:371-377.
59. Fitzgerald, K.A., S.M. McWhirter, K.L. Faia, et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
60. Fortes, P., A. Beloso, and J. Ortin. 1994. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13:704-712.
61. Foy, E., K. Li, C. Wang, et al. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
62. Francois, C., G. Duverlie, D. Rebouillat, et al. 2000. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74:5587-5596.
63. Frolova, E.I., R.Z. Fayzulin, S.H. Cook, et al. 2002. Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J. Virol. 76:11254-11264.
64. Gale, M.J., Jr., M.J. Korth, and M.G. Katze. 1998. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin. Diagn. Virol. 10:157-162.
65. Garcia-Sastre, A. 2001. Inhibition of interferon-mediated antiviral responses by Influenza A viruses and other negative-strand RNA viruses. Virology 279:375-384.
66. Garcia-Sastre, A., A. Egorov, D. Matassov, et al. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330.
67. Garcin, D., J.B. Marq, S. Goodboum, et al. 2003. The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J. Virol. 77:2321-2329.
68. Garcin, D., J.B. Marq, F. Iseni, et al. 2004. A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability. J. Virol. 78:8799-8811.
69. Garcin, D., J.B. Marq, L. Strahle, et al. 2002. All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295:256-265.
70. Goodbourn, S., L. Didcock, and R.E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341-2364.
71. Gotoh, B., K. Takeuchi, T. Komatsu, et al. 2003. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J. Virol. 77:3360-3370.
72. Graff, J.W., D.N. Mitzel, C.M. Weisend, et al. 2002. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J. Virol. 76:9545-9550.
73. Grieder, F.B., and S.N. Vogel. 1999. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 257:106-118.
74. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, et al. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
75. Gunnery, S., A.P. Rice, H.D. Robertson, et al. 1990. Tatresponsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87:8687-8691.
76. Guo, J., D.J. Hui, W.C. Merrick, et al. 2000. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J. 19:6891-6899.
77. Hagmaier, K., S. Jennings, J. Buse, et al. 2003. Novel gene product of thogoto virus segment 6 codes for an interferon antagonist. J. Virol. 77:2747-2752.
78. Haller, O., M. Frese, and G. Kochs. 1998. Mx proteins: mediators of innate resistance to RNA viruses. Rev. Sci. Tech. 17:220-230.
79. Haller, O., M. Frese, D. Rost, et al. 1995. Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 69:2596-2601.
80. Haller, O., and G. Kochs. 2002. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3:710-717.
81. Hatada, E., S. Saito, and R. Fukuda. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73:2425-2433.
82. He, B., M. Gross, and B. Roizman. 1997. The gamma(1)34.5 protein of herpes simplex viras 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843-848.
83. He, B., R.G. Paterson, N. Stock, et al. 2002. Recovery of paramyxovirus simian virus 5 with a v protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303:15-32.
84. Hefti, H.P., M. Frese, H. Landis, et al. 1999. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J. Virol. 73:6984-6991.
85. Heil, F., H. Hemmi, H. Hochrein, et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529.
86. Heim, M.H., D. Moradpour, and H.E. Blum. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73:8469-8475.
87. Her, L.S., E. Lund, and J.E. Dahlberg. 1997. Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276:1845-1848.
88. Hiscott, J., P. Pitha, P. Genin, et al. 1999. Triggering the interferon response: the role of IRF-3 transcription factor. J. Interferon Cytokine Res. 19:1-13.
89. Horisberger, M.A., P. Staeheli, and O. Haller. 1983. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. USA 80:1910-1914.
90. Huang, T., J. Pavlovic, P. Staeheli, et al. 1992. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J. Virol. 66:4154-4160.
91. Hui, D.J., C.R. Bhasker, W.C. Merrick, et al. 2003. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J. Biol. Chem. 278:39477-39482.
92. Hunter, W.D., R.L. Martuza, F. Feigenbaum, et al. 1999. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J. Virol. 73:6319-6326.
93. Hwang, S.Y., P.J. Hertzog, K.A. Holland, et al. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92:11284-11288.
94. Imani, F., and B.L. Jacobs. 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA 85:7887-7891.
95. Iqbal, M., E. Poole, S. Goodbourn, et al. 2004. Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double-stranded RNA. J. Virol. 78:136-145.
96. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147:258-267.
97. Iwamura, T., M. Yoneyama, K. Yamaguchi, et al. 2001. Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6:375-388.
98. Jacobs, B.L., J.O. Langland, and T. Brandt. 1998. Characterization of viral double-stranded RNA-binding proteins. Methods 15:225-232.
99. Jennings, S., L. Martínez-Sobrido, A. García-Sastre, et al. 2004. Thogoto virus ML protein suppresses IRF3 function. Virology (in press).
100. Juang, Y.-T., W. Lowther, M. Kellum, et al. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95:9837-9842.
101. Kato, A., Y. Ohnishi, M. Kohase, et al. 2001. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75: 3802-3810.
102. Khan, S., A. Zimmermann, M. Basler, et al. 2004. A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J. Virol. 78: 1831-1842.
103. Kim, K.I., and D.E. Zhang. 2003. ISG15, not just another ubiquitin-like protein. Biochem. Biophys. Res. Commun. 307:431-434.
104. Kim, M.J., A.G. Latham, and R.M. Krug. 2002. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc. Natl. Acad. Sci. USA 99:10096-10101.
105. Kochs, G., and O. Haller. 1999. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J. Biol. Chem. 274:4370-4376.
106. Kochs, G., and O. Haller. 1999. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. USA 96:2082-2086.
107. Kochs, G., C.H. Janzen, H. Hohenberg, et al. 2002. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl. Acad. Sci. USA 99:3153-3158.
108. Komatsu, T., K. Takeuchi, J. Yokoo, et al. 2004. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 325:137-148.
109. Kotenko, S.V., G. Gallagher, V.V. Baurin, et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
110. Krug, R.M., M. Shaw, B. Broni, et al. 1985. Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 56:201-206.
111. Krug, R.M., W. Yuan, D.L. Noah, et al. 2003. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181-189.
112. Kubota, T., N. Yokosawa, S. Yokota, et al. 2002. Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J. Virol. 76:12676-12682.
113. Langland, J.O., S. Pettiford, B. Jiang, et al. 1994. Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J. Virol. 68:3821-3829.
114. Laurent, A.M., J.J. Madjar, and A. Greco. 1998. Translational control of viral and host protein synthesis during the course of herpes simplex virus type 1 infection: evidence that initiation of translation is the limiting step. J. Gen. Virol. 79(Pt 11):2765-2775.
115. Le May, N., S. Dubaele, L.P. De Santis, et al. 2004. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541-550.
116. Lee, T.G., J. Tomita, A.G. Hovanessian, et al. 1990. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA 87:6208-6212.
117. Leonard, G.T., and G.C. Sen. 1996. Effects of adenovirus E1A protein on interferon-signaling. Virology 224:25-33.
118. Levy, D.E., and A. Garcia-Sastre. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12:143-156.
119. Levy, D.E., I. Marie, and A. Prakash. 2003. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15:52-58.
120. Levy, D.E., and I. J. Marie. 2004. RIGging an antiviral defense-it's in the CARDs. Nat. Immunol. 5:699-701.
121. Li, M., H. Lee, J. Guo, et al. 1998. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J. Virol. 72:5433-5440.
122. Li, S., S. Labrecque, M.C. Gauzzi, et al. 1999. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727-5737.
123. Li, Y., Z.Y. Chen, W. Wang, et al. 2001. The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA 7:920-931.
124. Lin, R., P. Genin, Y. Mamane, et al. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20:6342-6353.
125. Lin, R., C. Heylbroeck, P.M. Pitha, et al. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
126. Lin, R.J., C.L. Liao, E. Lin, et al. 2004. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J. Virol. 78: 9285-9294.
127. Lindenmann, J. 1960. Interferon und inverse Interferenz. Zeitschr. Hygiene 146:287-309.
128. Look, D.C., W.T. Roswit, A.G. Frick, et al. 1998. Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871-880.
129. Lu, Y., M. Wambach, M.G. Katze, et al. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214:222-228.
130. Lubyova, B., M.J. Kellum, A.J. Frisancho, et al. 2004. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J. Biol. Chem. 279:7643-7654.
131. Lubyova, B., and P.M. Pitha. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74:8194-8201.
132. Ludwig, S., X. Wang, C. Ehrhardt, et al. 2002. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76:11166-11171.
133. Lund, J.M., L. Alexopoulou, A. Sato, et al. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101:5598-5603.
134. Lyles, D.S. 2000. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol. Mol. Biol. Rev. 64:709-724.
135. Malakhova, O.A., M. Yan, M.P. Malakhov, et al. 2003. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17:455-460.
136. Marcus, P.I., L.L. Rodriguez, and M.J. Sekellick. 1998. Interferon induction as a quasispecies marker of vesicular stomatitis virus populations. J. Virol. 72:542-549.
137. Marcus, P.I., M.J. Sekellick, and S.T. Nichol. 1992. Interferon induction by viruses. XXI. Vesicular stomatitis virus: interferon inducibility as a phylogenetic marker. J. Interferon Res. 12:297-305.
138. Marie, I., J.E. Durbin, and D.E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
139. Martinand, C., C. Montavon, T. Salehzada, et al. 1999. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J. Virol. 73:290-296.
140. Martinand, C., T. Salehzada, M. Silhol, et al. 1998. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus (EMCV)-infected cells. Eur. J. Biochem. 254:248-255.
141. Mathews, M.B., and T. Shenk. 1991. Adenovirus virus-associated RNA and translation control. J. Virol. 65:5657-5662.
142. Maul, G.G., A.M. Ishov, and R.D. Everett. 1996. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217:67-75.
143. Maul, G.G., D. Negorev, P. Bell, et al. 2000. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129:278-287.
144. Melroe, G.T., N.A. DeLuca, and D.M. Knipe. 2004. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78:8411-8420.
145. Mineta, T., S.D. Rabkin, T. Yazaki, et al. 1995. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1:938-943.
146. Moller, A., and M.L. Schmitz. 2003. Viruses as hijackers of PML nuclear bodies. Arch. Immunol. Ther. Exp. (Warsz.) 51:295-300.
147. Muller, S., and A. Dejean. 1999. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73:5137-5143.
148. Muller, S., M.J. Matunis, and A. Dejean. 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61-70.
149. Muller, U., U. Steinhoff, L.F. Reis, et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
150. Mundschau, L.J., and D.V. Faller. 1995. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270:3100-3106.
151. Munoz-Jordan, J.L., G.G. Sanchez-Burgos, M. Laurent-Rolle, et al. 2003. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100:14333-14338.
152. Murphy, J.A., R.J. Duerst, T.J. Smith, et al. 2003. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J. Virol. 77:9337-9345.
153. Naniche, D., A. Yeh, D. Eto, et al. 2000. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J. Virol. 74:7478-7484.
154. Nishio, M., D. Garcin, V. Simonet, et al. 2002. The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif. Virology 300:92-99.
155. Noah, D.L., M.A. Blum, and B. Sherry. 1999. Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures. J. Virol. 73:10208-10213.
156. Noah, D.L., K.Y. Twu, and R.M. Krug. 2003. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 307:386-395.
157. Palosaari, H., J.P. Parisien, J.J. Rodriguez, et al. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:7635-7644.
158. Parisien, J.P., J.F. Lau, and C.M. Horvath. 2002. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76:6435-6441.
159. Parisien, J.P., J.F. Lau, J.J. Rodriguez, et al. 2001. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283:230-239.
160. Paulson, M., C. Press, E. Smith, et al. 2002. IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat. Cell. Biol. 4:140-147.
161. Pavlovic, J., H.A. Arzet, H.P. Hefti, et al. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:4506-4510.
162. Pavlovic, J., O. Haller, and P. Staeheli. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:2564-2569.
163. Peters, G.A., D. Khoo, I. Mohr, et al. 2002. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 76:11054-11064.
164. Pichlmair, A., J. Buse, S. Jennings, et al. 2004. Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice. J. Virol. 78.
165. Poole, E., B. He, R.A. Lamb, et al. 2002. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303:33-46.
166. Poppers, J., M. Mulvey, D. Khoo, et al. 2000. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J. Virol. 74:11215-11221.
167. Prakash, B., G.J. Praefcke, L. Renault, et al. 2000. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403: 567-571.
168. Puehler, F., K.C. Weining, J.A. Symons, et al. 1998. Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-gamma. Virology 248:231-240.
169. Regad, T., and M.K. Chelbi-Alix. 2001. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20:7274-7286.
170. Regad, T., A. Saib, V. Lallemand-Breitenbach, et al. 2001. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J. 20:3495-3505.
171. Reichelt, M., S. Stertz, J. Krijnse-Locker, et al. 2004. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 5:772-784.
172. Roberts, R.M., T. Ezashi, C.S. Rosenfeld, et al. 2003. Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod. Suppl. 61:239-251.
173. Rodriguez, J.J., J.P. Parisien, and C.M. Horvath. 2002. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76:11476-11483.
174. Rodriguez, J.J., L.F. Wang, and C.M. Horvath. 2003. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J. Virol. 77:11842-11845.
175. Roers, A., H.K. Hochkeppel, M.A. Horisberger, et al. 1994. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 169:807-813.
176. Ronco, L.V., A.Y. Karpova, M. Vidal, et al. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:2061-2072.
177. Roy, S., M.G. Katze, N.T. Parkin, et al. 1990. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219.
178. Ruggli, N., J.D. Tratschin, M. Schweizer, et al. 2003. Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro). J. Virol. 77:7645-7654.
179. Ryman, K.D., W.B. Klimstra, K.B. Nguyen, et al. 2000. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74:3366-3378.
180. Saito, S., T. Ogino, N. Miyajima, et al. 2002. Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology 293:205-209.
181. Samuel, C.E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
182. Sato, M., H. Suemori, N. Hata, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548.
183. Schafer, S.L., R. Lin, P.A. Moore, et al. 1998. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273:2714-2720.
184. Schlender, J., B. Bossert, U. Buchholz, et al. 2000. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74:8234-8242.
185. Schweizer, M., and E. Peterhans. 2001. Noncytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis. J. Virol. 75:4692-4698.
186. Sen, G.C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
187. Seo, S.H., E. Hoffmann, and R.G. Webster. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine response. Nat. Med. 8:950-954:
188. Shaffer, J.A., W.J. Bellini, and P.A. Rota. 2003. The C protein of measles virus inhibits the type I interferon response. Virology 315:389-397.
189. Sharma, S., B.R. TenOever, N. Grandvaux, et al. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
190. Shaw, M.L., A. Garcia-Sastre, P. Palese, et al. 2004. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 78:5633-5641.
191. Sheppard, P., W. Kindsvogel, W. Xu, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
192. Sherry, B., J. Torres, and M.A. Blum. 1998. Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J. Virol. 72:1314-1323.
193. Silverman, R.H. 1994. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J. Interferon Res. 14:101-104.
194. Silverman, R.H. 2003. Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812.
195. Simon, A., J. Fah, O. Haller, et al. 1991. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J. Virol. 65:968-971.
196. Smiley, J.R. 2004. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J. Virol. 78:1063-1068.
197. Smith, E.J., I. Marie, A. Prakash, et al. 2001. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by vaccinia virus E3L protein. J. Biol. Chem. 276:8951-8957.
198. Spann, K.M., K.C. Tran, B. Chi, et al. 2004. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78:4363-4369.
199. Staeheli, P., O. Haller, W. Boll, et al. 1986. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-158.
200. Stark, G.R., I.M. Kerr, B.R. Williams, et al. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
201. Sternsdorf, T., K. Jensen, and H. Will. 1997. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell. Biol. 139:1621-1634.
202. Stojdl, D.F., B. Lichty, S. Knowles, et al. 2000. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6:821-825.
203. Stojdl, D.F., B.D. Lichty, B.R. tenOever, et al. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275.
204. Strong, J.E., M.C. Coffey, D. Tang, et al. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17:3351-3362.
205. Suhara, W., M. Yoneyama, I. Kitabayashi, et al. 2002. Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J. Biol. Chem. 277:22304-22313.
206. Symons, J.A., A. Alcami, and G.L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560.
207. Tabeta, K., P. Georgel, E. Janssen, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101:3516-3521.
208. Takeuchi, K., T. Komatsu, J. Yokoo, et al. 2001. Sendai virus C protein physically associates with Stat1. Genes Cells 6:545-557.
209. Talon, J., C.M. Horvath, R. Polley, et al. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74:7989-7996.
210. Talon, J., M. Salvatore, R.E. O'Neill, et al. 2000. Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc. Natl. Acad. Sci. USA 97:4309-4314.
211. Taylor, D.R., S.T. Shi, P.R. Romano, et al. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
212. Thimme, R., J. Bukh, H.C. Spangenberg, et al. 2002. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 99:15661-15668.
213. Thomas, D., G. Blakqori, V. Wagner, et al. 2004. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J. Biol. Chem. 279:31471-31477.
214. Turelli, P., V. Doucas, E. Craig, et al. 2001. Cytoplasmic recruitment of INII and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7:1245-1254.
215. Ulane, C.M., J.J. Rodriguez, J.P. Parisien, et al. 2003. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J. Virol. 77:6385-6393.
216. Valarcher, J.F., J. Furze, S. Wyld, et al. 2003. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J. Virol. 77:8426-8439.
217. van den Broek, M.F., U. Muller, S. Huang, et al. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
218. van Pesch, V., H. Lanaya, J.C. Renauld, et al. 2004. Characterization of the murine alpha interferon gene family. J. Virol. 78:8219-8228.
219. van Pesch, V., O. van Eyll, and T. Michiels. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811-7817.
220. Van Sant, C., R. Hagglund, P. Lopez, et al. 2001. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. USA 98:8815-8820.
221. Vyas, J., A. Elia, and M.J. Clemens. 2003. Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. RNA 9:858-870.
222. Wang, C., J. Pflugheber, R. Sumpter, Jr., et al. 2003. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77:3898-3912.
223. Wang, Q., J. Bergeron, T. Mabrouk, et al. 1996. Site-directed mutagenesis of the double-stranded RNA binding domain of bacterially-expressed sigma 3 reovirus protein. Virus Res. 41:141-151.
224. Wang, W., and R.M. Krug. 1996. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223:41-50.
225. Wang, X., M. Li, H. Zheng, et al. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74:11566-11573.
226. Wansley, E.K., and G.D. Parks. 2002. Naturally occurring substitutions in the p/v gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J. Virol. 76:10109-10121.
227. Wathelet, M.G., C.H. Lin, B.S. Parekh, et al. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1:507-518.
228. Weaver, B.K., K.P. Kumar, and N.C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell Biol. 18:1359-1368.
229. Weber, F., A. Bridgen, J.K. Fazakerley, et al. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J. Virol. 76:7949-7955.
230. Weber, F., O. Haller, and G. Kochs. 2000. MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J. Virol. 74:560-563.
231. Weber, F., G. Kochs, O. Haller, et al. 2003. Viral evasion of the interferon system: old viruses, new tricks. J. Interferon Cytokine Res. 23:209-213.
232. Weihua, X., S. Ramanujam, D.J. Lindner, et al. 1998. The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc. Natl. Acad. Sci. USA 95:1085-1090.
233. Williams, B.R. 1999. PKR; a sentinel kinase for cellular stress. Oncogene 18:6112-6120.
234. Xiang, Y., R.C. Condit, S. Vijaysri, et al. 2002. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J. Virol. 76:5251-5259.
235. Yalamanchili, P., K. Harris, E. Wimmer, et al. 1996. Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. J. Virol. 70:2922-2929.
236. Yang, Y.L., L.F. Reis, J. Pavlovic, et al. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-6106.
237. Yokota, S., H. Saito, T. Kubota, et al. 2003. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Virology 306:135-146.
238. Yokota, S., N. Yokosawa, T. Okabayashi, et al. 2004. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 78:6282-6286.
239. Yoneyama, M., M. Kikuchi, T. Natsukawa, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
240. Yoneyama, M., W. Suhara, Y. Fukuhara, et al. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1087-1095.
241. Young, D.F., L. Didcock, S. Goodbourn, et al. 2000. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269: 383-390.
242. Yuan, H., B.K. Yoza, and D.S. Lyles. 1998. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. Virology 251:383-392.
243. Yuan, W., and R.M. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-371.
244. Zhou, A., J. Paranjape, T.L. Brown, et al. 1997. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate- dependent RNase L. EMBO J. 16:6355-6363.
245. Zhou, A., J.M. Paranjape, S.D. Der, et al. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440.
246. Zimring, J.C., S. Goodbourn, and M.K. Offermann. 1998. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72:701-707.